Ancel D, Amiot X, Chaslin-Ferbus D, Hagege I, Garioud A, Girot R

Complications
Ancel D, Amiot X, Chaslin-Ferbus D, Hagege I, Garioud A, Girot R, Pol S,Grange JD. Treatment
of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and
ribavirin. Eur J Gastroenterol Hepatol. 2009 Jul;21(7):726-9.
Rasekhi AR, Naderifar M, Bagheri MH, Shahriari M, Foroutan H, Karimi M, Nabavizadeh SA.
Radiofrequency ablation of the spleen in patients with thalassemia intermedia: a pilot study.
AJR Am J Roentgenol. 2009 May;192(5):1425-9.
Cianciulli P. Treatment of iron overload in thalassemia. Pediatr Endocrinol Rev. 2008 Oct;6
Suppl 1:208-13. Review.
De Sanctis V, Govoni MR, Sprocati M, Marsella M, Conti E. Cardiomyopathy and pericardial
effusion in a 7 year-old boy with beta-thalassaemia major, severe primary hypothyroidism and
hypoparathyroidism due to iron overload. Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:181-4.
Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism,
hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in
patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr
Endocrinol Rev. 2008 Oct;6 Suppl 1:158-69.
Soliman A, Adel A, Bedair E, Wagdy M. An adolescent boy with thalassemia major presenting
with bone pain, numbness, tetanic contractions and growth and pubertal delay:
panhypopituitarism and combined vitamin D and parathyroid defects. Pediatr Endocrinol Rev.
2008 Oct;6 Suppl 1:155-7.
Skordis N, Ioannou YS, Kyriakou A, Savva SC, Efstathiou E, Savvides I, Christou S. Effect of
bisphosphonate treatment on bone mineral density in patients with thalassaemia major. Pediatr
Endocrinol Rev. 2008 Oct;6 Suppl 1:144-8.
Voskaridou E, Terpos E. Pathogenesis and management of osteoporosis in thalassemia.
Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:86-93. Review.
Angastiniotis M, Eleftheriou A. Thalassaemic bone disease. An overview. Pediatr Endocrinol
Rev. 2008 Oct;6 Suppl 1:73-80. Review.
Staretz-Chacham O, Lang TC, LaMarca ME, Krasnewich D, Sidransky E. Lysosomal storage
disorders in the newborn. Pediatrics. 2009 Apr;123(4):1191-207. Review.
Briand N, Pornprasert S, Ngo-Giang-Huong N, Galactéros F, Pissard S, Tatu T, Sanguansermsri T, Jourdain G, Lallemant M, Le Coeur S. Perinatal zidovudine prophylaxis in
HIV type-1-infected pregnant women with thalassaemia carriage in Thailand. Antivir Ther.
2009;14(1):117-22.
Field JJ, Strunk RC, Knight-Perry JE, Blinder MA, Townsend RR, DeBaun MR. Urinary cysteinyl
leukotriene E4 significantly increases during pain in children and adults with sickle cell disease.
Am J Hematol. 2009 Apr;84(4):231-3.
1/3
Complications
Geffner ME, Karlsson H. Use of recombinant human growth hormone in children with
thalassemia. Horm Res. 2009 Jan;71 Suppl 1:46-50.
Gumiero AP, Bellomo-Brandão MA, da Costa-Pinto EA. Gallstones in children with sickle cell
disease followed up at a Brazilian hematology center. Arq Gastroenterol. 2008
Oct-Dec;45(4):313-8.
Chouliaras G, Yiannoutsos CT, Berdoukas V, Ladis V. Cardiac related death in thalassaemia
major: time trend and risk factors in a large Greek Unit. Eur J Haematol. 2009 May;82(5):381-7.
Parakh A, Sudha S, Dubey AP, Gupta A. Celiac disease in a child with beta-thalassemia major:
a need for improved screening and awareness. J Pediatr Hematol Oncol. 2008
Dec;30(12):913-4.
Obeidat N, Amarin Z, Obeidat B. Successful maternal digoxin therapy of supraventricular
tachycardia in a fetus with hydrops. J Obstet Gynaecol. 2008 Nov;28(8):803-6.
Karimi M, Borzouee M, Mehrabani A, Cohan N. Echocardiographic finding in beta-thalassemia
intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in
beta-thalassemia intermedia. Eur J Haematol. 2009 Mar;82(3):213-8.
de Witte T. The role of iron in patients after bone marrow transplantation. Blood Rev. 2008
Dec;22 Suppl 2:S22-8. Review.
Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev. 2008
Dec;22 Suppl 2:S14-21. Review.
El-Beshlawy A, Youssry I, El-Saidi S, El Accaoui R, Mansi Y, Makhlouf A, Taher A. Pulmonary
hypertension in beta-thalassemia major and the role of L-carnitine therapy. Pediatr Hematol
Oncol. 2008 Dec;25(8):734-43.
Pistorius LR, Smal J, de Haan TR, Page-Christiaens GC, Verboon-Maciolek M, Oepkes D, de
Vries LS. Disturbance of cerebral neuronal migration following congenital parvovirus B19
infection. Fetal Diagn Ther. 2008;24(4):491-4.
Meo A, Cassinerio E, Castelli R, Bignamini D, Perego L, Cappellini MD. Effect of hydroxyurea
on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature
review. Int J Lab Hematol. 2008 Oct;30(5):425-31. Review.
Di Matteo R, Liuzza F, Manicone PF, Raffaelli L, Berardi D, Perfetti G, Maccauro G. Bone and
maxillofacial abnormalities in thalassemia: a review of the literature. J Biol Regul Homeost
Agents. 2008 Oct-Dec;22(4):211-6. Review.
Bunce PE, Mishra S, Gold WL. Iron-clad diagnosis. Am J Med. 2008 Dec;121(12):1043-5.
2/3
Complications
Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD.
High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol.
2009 Jan;84(1):29-33.
Dormandy E, Kavalier F, Logan J, Harris H, Ishmael N, Marteau TM; SHIFT research team.
Maximising recruitment and retention of general practices in clinical trials: a case study. Br J
Gen Pract. 2008 Nov;58(556):759-66.
Davison SM, Kelly DA. Management strategies for hepatitis C virus infection in children.
Paediatr Drugs. 2008;10(6):357-65. Review.
Michlitsch JG, Walters MC. Recent advances in bone marrow transplantation in
hemoglobinopathies. Curr Mol Med. 2008 Nov;8(7):675-89. Review.
Singer ST, Ataga KI. Hypercoagulability in sickle cell disease and beta-thalassemia. Curr Mol
Med. 2008 Nov;8(7):639-45. Review.
Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med. 2008
Nov;8(7):609-19. Review.
Goldschmidt N, Spectre G, Brill A, Zelig O, Goldfarb A, Rachmilewitz E, Varon D. Increased
platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood
cells. Thromb Haemost. 2008 Nov;100(5):864-70.
Shenkman B. Thrombotic complications in thalassemic patients: contribution of red blood cells
and platelets. Thromb Haemost. 2008 Nov;100(5):735.
Bernardo ME, Zecca M, Piras E, Vacca A, Giorgiani G, Cugno C, Caocci G, Comoli P,
Mastronuzzi A, Merli P, La Nasa G, Locatelli F. Treosulfan-based conditioning regimen for
allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. Br J
Haematol. 2008 Nov;143(4):548-51.
Trad O, Hamdan MA, Jamil A, Khanani MF, Ishaqi MK, Shamsi A, Hayek M. Reversal of
iron-induced dilated cardiomyopathy during therapy with deferasirox in beta-thalassemia.
Pediatr Blood Cancer. 2009 Mar;52(3):426-8.
3/3